Ireland
--:--IST
Latest
Clinical Trials in France / NCT04374175
Recruiting Observational

SERum-bank for PANcreatic Cancer

NCT04374175 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2020-04-01
Last updated
2025-03-18

Condition(s) studied

Adenocarcinoma

Investigational drug(s) / intervention(s)

Blood sample →

Blood sample: Blood sample will be performed

Study summary

This study is about pancreatic cancer. If the diagnostic cancer is done at an early stage (\<2cm), the chances of recovery are very good.

But the main problem is there is not any detections means for this cancer. Sadly, when there is a cancer diagnostic , it's already too late in the majority of cases, because the cancer is in an advanced case.

Today, there is no any effective means of detection... Blood markers can be a simple means of early detection

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
ADENOCARCINOMA GROUP Inclusion Criteria: * Documented adenocarcinoma (cytology / anatomopathology), all stages, except if the tumor is immediately resectable and does not require preoperative cytological evidence. In this case, the inclusion and the first collection of the sero bank is done preoperatively. The diagnostic confirmation will therefore be made post-operatively at the risk of being excluded in the event of a different diagnosis. * At the start of treatment (before surgery / 1st course of chemotherapy) * Age ≥ 18 years * Patient affiliated or entitled to a social security system Exclusion Criteria: * Patient refusal * Acute renal failure * Child-Pugh B or C cirrhosis * Patient under guardianship or curators * Other synchronous cancer or history of cancer \<5 years * Language barrier CONTROL GROUP Inclusion Criteria: * Age ≥ 40 years * Patient affiliated or entitled to a social security system * Digestive endoscopy for any reason other than cancer or chronic inflammatory bowel disease Exclusion Criteria: * Patient refusal * Acute renal failure * Child-Pugh B or C cirrhosis * Patient under guardianship or curators * Other synchronous cancer or history of cancer \<5 years

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
CHU Saint-Etienne Saint-Etienne France Recruiting
Institut Cancérologique Lucien Newirth (ICLN) Saint-Priest-en-Jarez France Recruiting

More Centre Hospitalier Universitaire de Saint Etienne trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04374175 on ClinicalTrials.gov ↗ ← All trials in France